Table 4.
Males |
Females |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Self-Identified Race |
Biogeographic Ancestry |
Self-Identified Race |
Biogeographic Ancestry |
|||||||||
ORb | 95% CI | P Valuec | OR | 95% CI | P Value | OR | 95% CI | P Value | OR | 95% CI | P Value | |
Metabolic syndromed | NS | NS | NS | NS | NS | 0.001 | NS | NS | <0.0001 | NS | NS | 0.005 |
Glucose | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | ||
Triglycerides | 0.4 | 0.2, 0.6 | 0.004 | NS | NS | NS | 0.4 | 0.3, 0.6 | <0.0005 | 0.7 | 0.6, 0.8 | <0.0005 |
Hypertension | 2.1 | 1.1, 3.8 | 0.02 | 1.3 | 1.0, 1.3 | 0.04 | NS | NS | NS | NS | NS | NS |
Coronary artery calcification | 0.3 | 0.1, 0.8 | 0.03 | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Abbreviations: CI, confidence interval; Heart SCORE, Heart Strategies Concentrating on Risk Evaluation; NS, not significant; OR, odds ratio.
a For definitions of variables, see Tables 1 and 2.
b Odds ratio for the presence of metabolic syndrome criteria.
c False discovery rate-adjusted, 2-sided P value. Significance was set at P < 0.05.
d Metabolic syndrome was defined according to National Cholesterol Education Program criteria; subjects were classified as “normal” (reference group), “with metabolic syndrome” (group 1), or “with a history of diabetes” (group 2) and compared using analysis of variance (males—self-identified race: NS; biogeographic ancestry: F = 4.9 (4 df); females—self-identified race: F = 1.4 (1 df); biogeographic ancestry: F = 3.7 (4 df)), with age, gender, smoking status, current physical activity level, education, and income as covariates. Individual components of the metabolic syndrome which did not use gender-specific cutoffs were evaluated by means of logistic regression, with age, smoking status, current physical activity level, education, and income as covariates in all models.